Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: First in-human results

Nature Medicine

Volumn 17, Issue 10, 2011, Pages 1315-1319

  Van Dam, Gooitzen M ^a   Themelis, George ^b   Crane, Lucia M A ^a,b   Harlaar, Niels J ^a   Pleijhuis, Rick G ^a   Kelder, Wendy ^b   Sarantopoulos, Athanasios ^a   De Jong, Johannes S ^c   Arts, Henriette J G ^c   Van Der Zee, Ate G J ^c   Bart, Joost ^a   Low, Philip S ^d   Ntziachristos, Vasilis ^b  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF GRONINGEN   (Netherlands)

^d PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOLATE RECEPTOR 1;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURGERY; CASE REPORT; CYTOREDUCTIVE SURGERY; FEMALE; FLUORESCENCE IMAGING; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRAOPERATIVE PERIOD; LAPAROTOMY; OVARY CANCER; PRIORITY JOURNAL; TISSUE SPECIFICITY;

AGED; DIAGNOSTIC IMAGING; FEMALE; FLUORESCEIN-5-ISOTHIOCYANATE; FOLATE RECEPTOR 1; HUMANS; MICROSCOPY, FLUORESCENCE; MIDDLE AGED; MOLECULAR STRUCTURE; MONITORING, INTRAOPERATIVE; OVARIAN NEOPLASMS;

EID: 80053989452     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.2472     Document Type: Article

References (32)

1. Jemal, A. et al. Cancer statistics, 2008. CA Cancer J. Clin. 58, 71-96 (2008). (Pubitemid 351521864)
2. Gondos, A., Bray, F., Hakulinen, T. & Brenner, H. Trends in cancer survival in 11 European populations from 1990 to 2009: a model-based analysis. Ann. Oncol. 20, 564-573 (2009).
3. Aletti, G.D., Gallenberg, M.M., Cliby, W.A., Jatoi, A. & Hartmann, L.C. Current management strategies for ovarian cancer. Mayo Clin. Proc. 82, 751-770 (2007). (Pubitemid 46878099)
4. Winter, W.E. III et al. Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study. J. Clin. Oncol. 26, 83-89 (2008).
5. Ibeanu, O.A. & Bristow, R.E. Predicting the outcome of cytoreductive surgery for advanced ovarian cancer: a review. Int. J. Gynecol. Cancer 20 (suppl. 1), S1-S11 (2010).
6. Troyan, S.L. et al. The FLARE intraoperative near-infrared fluorescence imaging system: a first-in-human clinical trial in breast cancer sentinel lymph node mapping. Ann. Surg. Oncol. 16, 2943-2952 (2009).
7. Luker, G.D. & Luker, K.E. Optical imaging: current applications and future directions. J. Nucl. Med. 49, 1-4 (2008).
8. Tromberg, B.J. et al. Assessing the future of diffuse optical imaging technologies for breast cancer management. Med. Phys. 35, 2443-2451 (2008). (Pubitemid 351748652)
9. Kirsch, D.G. et al. A spatially and temporally restricted mouse model of soft tissue sarcoma. Nat. Med. 13, 992-997 (2007). (Pubitemid 47222037)
10. von Burstin, J. et al. Highly sensitive detection of early-stage pancreatic cancer by multimodal near-infrared molecular imaging in living mice. Int. J. Cancer 123, 2138-2147 (2008).
11. Sevick-Muraca, E.M. et al. Imaging of lymph flow in breast cancer patients after microdose administration of a near-infrared fluorophore: feasibility study. Radiology 246, 734-741 (2008).
12. Tagaya, N. et al. Intraoperative identification of sentinel lymph nodes by near-infrared fluorescence imaging in patients with breast cancer. Am. J. Surg. 195, 850-853 (2008). (Pubitemid 351749448)
13. Stummer, W. et al. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol. 7, 392-401 (2006).
14. Kalli, K.R. et al. Folate receptor alpha as a tumor target in epithelial ovarian cancer. Gynecol. Oncol. 108, 619-626 (2008).
15. Markert, S. et al. Alpha-folate receptor expression in epithelial ovarian carcinoma and non-neoplastic ovarian tissue. Anticancer Res. 28, 3567-3572 (2008).
16. Mathias, C.J. et al. Indium-111-DTPA-folate as a potential folate-receptor-targeted radiopharmaceutical. J. Nucl. Med. 39, 1579-1585 (1998). (Pubitemid 28459891)
17. Armstrong, D.K. et al. Exploratory phase II efficacy study of MORAb-003, a monoclonal antibody against folate receptor alpha, in platinum-sensitive ovarian cancer in first relapse. J. Clin. Oncol. 26, 5500 (2008).
18. Kennedy, M.D., Jallad, K.N., Thompson, D.H., Ben Amotz, D. & Low, P.S. Optical imaging of metastatic tumors using a folate-targeted fluorescent probe. J. Biomed. Opt. 8, 636-641 (2003).
19. Leamon, C.P. et al. Synthesis and biological evaluation of EC20: a new folate-derived, 99mTc-based radiopharmaceutical. Bioconjug. Chem. 13, 1200-1210 (2002). (Pubitemid 35420011)
20. Themelis, G., Yoo, J.S., Soh, K.S., Schulz, R. & Ntziachristos, V. Real-time intraoperative fluorescence imaging system using light-absorption correction. J. Biomed. Opt. 14, 064012 (2009).
21. Sega, E.I. & Low, P.S. Tumor detection using folate receptor-targeted imaging agents. Cancer Metastasis Rev. 27, 655-664 (2008).
22. Crane, L.M.A. et al. The effect of chemotherapy on expression of folate receptor-α in ovarian cancer. Cell. Oncol. Published online, doi: 10.1007/s13402-011-0052-6.
23. Vergote, I. et al. Timing of debulking surgery in advanced ovarian cancer. Int. J. Gynecol. Cancer 18 (suppl. 1), 11-19 (2008). (Pubitemid 351389047)
24. Aletti, G.D. et al. Aggressive surgical effort and improved survival in advanced-stage ovarian cancer. Obstet. Gynecol. 107, 77-85 (2006).
25. Koppe, M.J., Boerman, O.C., Oyen, W.J. & Bleichrodt, R.P. Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies. Ann. Surg. 243, 212-222 (2006). (Pubitemid 43185440)
26. Low, P.S. & Antony, A.C. Folate receptor-targeted drugs for cancer and inflammatory diseases. Adv. Drug Deliv. Rev. 56, 1055-1058 (2004). (Pubitemid 38496506)
27. Parker, N. et al. Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay. Anal. Biochem. 338, 284-293 (2005). (Pubitemid 40312593)
28. Troy, T., Jekic-McMullen, D., Sambucetti, L. & Rice, B. Quantitative comparison of the sensitivity of detection of fluorescent and bioluminescent reporters in animal models. Mol. Imaging 3, 9-23 (2004).
29. Benedet, J.L., Bender, H., Jones, H. III, Ngan, H.Y. & Pecorelli, S. FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology. Int. J. Gynaecol. Obstet. 70, 209-262 (2000).
30. Lu, Y. & Low, P.S. Folate targeting of haptens to cancer cell surfaces mediates immunotherapy of syngeneic murine tumors. Cancer Immunol. Immunother. 51, 153-162 (2002). (Pubitemid 34298111)
31. Lu, Y. et al. Strategy to prevent drug-related hypersensitivity in folate-targeted hapten immunotherapy of cancer. AAPS J. 11, 628-638 (2009).
32. Themelis, G., Yoo, J.S. & Ntziachristos, V. Multispectral imaging using multiple-bandpass filters. Opt. Lett. 33, 1023-1025 (2008).